Nature Reviews Clinical Oncology · Nov 17, 2026

Global landscape of early-onset breast cancer: from understanding risk to precision prevention and cancer interception

By Wu S, Semprini J, Manirakiza AVC et al.

Early-onset breast cancer (EOBC), defined in this Review as breast cancer diagnosed before 50 years of age, accounts for a growing proportion of global breast cancer incidence and is associated with disproportionately unfavourable outcomes. Although inherited susceptibility contributes to EOBC risk, the rising incidence and persistent disparities that characterize EOBC cannot be explained by genetics alone; molecular subtype distribution, modifiable exposures and healthcare-related factors also affect presentation, response to treatment and outcomes. In this Review, we synthesize epidemiological trends, providing an overview of the inherited and multifactorial risk determinants, tumour subtype distributions and modifiable exposures that shape EOBC across populations. We examine why age-based screening paradigms do not fully capture EOBC risk and discuss approaches to risk-informed early detection and diagnosis, emphasizing the need for prompt histopathological confirmation and biomarker-guided care. We then address structural and healthcare-related barriers that constrain implementation of such an approach, including diagnostic capacity, pathology infrastructure, treatment affordability and financial toxicity. Finally, we propose a roadmap for the prevention, early diagnosis and interception of EOBC that integrates family history, germline testing, ancestry-aware risk models, pathology, treatment access and resource-stratified implementation. We argue that biological risk architecture must be aligned with healthcare systems that translate risk recognition into prompt, equitable and optimal management, including appropriately adapted treatment, ultimately improving outcomes for patients with EOBC.

doi.org/10.1038/s41571-026-01222-2PubMed 43045792Populations

AgingResearch.News